Watch this short video to learn more about the STELLAR‑304 study

THE COMBINATION OF ZANZALINTINIB AND NIVOLUMAB HAS NOT BEEN APPROVED BY THE FDA. THE SAFETY AND EFFECTIVENESS OF THIS STUDY TREATMENT HAVE NOT BEEN PROVEN AND ARE BEING STUDIED AS PART OF THIS CLINICAL TRIAL.